| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer | Chief Financial Officer
1 company
Robb Gary Charles is a Chief Business Officer at CORCEPT THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $8.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | CORT Corcept Therapeutics Inc | Chief Business Officer | Sale+OE | 2,326 | $71.27 | $165,774.02 | -12.7% | +6.7% | - | |
| Jun 16, 2025 | CORT Corcept Therapeutics Inc | Chief Business Officer | Sell | 3,185 | $70.77 | $225,402.45 | -19.2% | -1.9% | - | |
| May 20, 2025 | CORT Corcept Therapeutics Inc | Chief Business Officer | Sell | 2,279 | $75.85 | $172,862.15 | -12.1% | -5.9% | - | |
| Jan 2, 2025 | CORT Corcept Therapeutics Inc | Chief Business Officer | Sale+OE | 11,000 | $50.50 | $555,551.70 | -35.3% | +67.7% | -23.6% | |
| Nov 22, 2024 | CORT Corcept Therapeutics Inc | Chief Business Officer | Sell | 2,609 | $56.20 | $146,625.80 | -11.5% | +13.1% | +34.3% | |
| Oct 1, 2024 | CORT Corcept Therapeutics Inc | Chief Business Officer | Sale+OE | 11,000 | $46.28 | $509,080.00 | -32.6% | +8.8% | +80.2% | |
| Aug 26, 2024 | CORT Corcept Therapeutics Inc | Chief Business Officer | Sell | 3,101 | $35.71 | $110,736.71 | -11.8% | +68.7% | +98.8% | |
| Jul 1, 2024 | CORT Corcept Therapeutics Inc | Chief Business Officer | Sale+OE | 11,000 | $32.49 | $357,390.00 | -29.5% | +41.7% | +112.2% | |
| May 28, 2024 | CORT Corcept Therapeutics Inc | Chief Business Officer | Sale+OE | 11,000 | $30.39 | $334,294.40 | -35.3% | +10.7% | +145.7% | |
| Dec 6, 2023 | CORT Corcept Therapeutics Inc | Chief Business Officer | Sale+OE | 7,593 | $26.88 | $204,063.33 | -13.4% | -14.3% | +119.7% |